SEC Form 4 · accession 0001127602-17-027733
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Helena Foulkes
Officer — EVP & President-CVS Pharmacy
Period of report
Sep 15, 2017
Accepted (ET)
Sep 19, 2017 · 4:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 15, 2017 | M | 39,340 | $54.53 | A | 84,337 | D | |
| Common StockF2 | Sep 15, 2017 | S | 39,340 | $81.88 | D | 44,997 | D | |
| Common Stock (restricted) | holding | — | — | — | 51,191 | D | ||
| ESOP Common Stock | holding | — | — | — | 4,071 | I | By ESOP | |
| Stock Unit | holding | — | — | — | 56,290 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF3 | $54.53 | Sep 15, 2017 | M | 39,340 | D | Apr 1, 2014 | Apr 1, 2020 | Common Stock | 39,340 | 0 | D |
| Stock OptionF4 | $45.07 | holding | — | — | — | Apr 2, 2013 | Apr 2, 2019 | Common Stock | 19,965 | 19,965 | D |
| Stock OptionF5 | $74.29 | holding | — | — | — | Apr 1, 2015 | Apr 1, 2021 | Common Stock | 52,452 | 52,452 | D |
| Stock OptionF6 | $102.26 | holding | — | — | — | Apr 1, 2016 | Apr 1, 2022 | Common Stock | 59,922 | 59,922 | D |
| Stock OptionF7 | $104.82 | holding | — | — | — | Apr 1, 2017 | Apr 1, 2023 | Common Stock | 71,696 | 71,696 | D |
| Stock OptionF8 | $78.05 | holding | — | — | — | Apr 3, 2018 | Apr 3, 2024 | Common Stock | 150,268 | 150,268 | D |
Explanation of responses
- F1All sales were effected pursuant to a Rule 10b5-1 plan.
- F2Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $81.51 and $82.11 per share.
- F3Option became exercisable in four equal annual installments, commencing 4/1/2014.
- F4Option became exercisable in four equal annual installments, commencing 4/2/2013.
- F5Option became exercisable in four equal annual installments, commencing 4/1/2015.
- F6Option became exercisable in four equal annual installments, commencing 4/1/2016.
- F7Option became exercisable in four equal annual installments, commencing 4/1/2017.
- F8Option becomes exercisable in four equal annual installments, commencing 4/3/2018.